A Randomised, Cross-over, Open-label, Multi-centre Trial Comparing the Effect of Insulin Degludec and Insulin Glargine 100U/mL, With or Without OADs in Subjects With Type 2 Diabetes Using Flash Glucose Monitoring
Phase of Trial: Phase IV
Latest Information Update: 07 Jan 2020
Price : $35 *
At a glance
- Drugs Insulin degludec (Primary) ; Insulin glargine
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms SWITCH PRO
- Sponsors Novo Nordisk
- 02 Jan 2020 Status changed from active, no longer recruiting to completed.
- 11 Apr 2019 Status changed from recruiting to active, no longer recruiting.
- 03 Oct 2018 Status changed from not yet recruiting to recruiting.